Immunovant
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunovant and other ETFs, options, and stocks.About IMVT
Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It is developing a novel, fully human monoclonal antibody IMVT-1401 that selectively binds to and inhibits the neonatal fragment crystallizable receptor.
IMVT Key Statistics
Stock Snapshot
As of today, Immunovant(IMVT) shares are valued at $24.80. The company's market cap stands at 4.98B, with a P/E ratio of -9.13.
As of 2026-04-03, Immunovant(IMVT) stock has fluctuated between $22.50 and $25.37. The current price stands at $24.80, placing the stock +10.2% above today's low and -2.2% off the high.
The Immunovant(IMVT)'s current trading volume is 2.02M, compared to an average daily volume of 1.58M.
During the past year, Immunovant(IMVT) stock moved between $12.72 at its lowest and $29.25 at its peak.
During the past year, Immunovant(IMVT) stock moved between $12.72 at its lowest and $29.25 at its peak.
Analyst ratings
72%
of 18 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.